Informations générales (source: ClinicalTrials.gov)

NCT06185491 En recrutement IDF
Assessment of HGI (Hemoglobin Glycation Index) Variability Over Time in Patients Living with Diabetes Using Continuous Glucose Monitoring (GAP OUEST)
Interventional
  • Diabète
N/A
Nantes University Hospital (Voir sur ClinicalTrials)
juin 2024
septembre 2027
05 avril 2025
The goal of this clinical trial is to learn about the variability of HGI (Hemoglobin Glycation Index) over time in patients living with diabetes using a continuous glucose monitoring.

Etablissements

Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données
HOPITAL NOVO CAMPINOS Catherine En recrutement IDF 14/02/2025 09:03:16  Contacter
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
CH de La Rochelle - 17019 - La Rochelle - France Didier GOUET Recrutement non commencé Contact (sur clinicalTrials)
CH du Mans - 72037 - Le Mans - France Charly VAILLANT En recrutement Contact (sur clinicalTrials)
CHU d'Angers - 49100 - Angers - France Claire BRIET En recrutement Contact (sur clinicalTrials)
CHU de Brest - 29200 - Brest - France Philippe THUILLIER En recrutement Contact (sur clinicalTrials)
CHU de Caen - 14033 - Caen - France Michael JOUBERT En recrutement Contact (sur clinicalTrials)
CHU de Nantes - 44093 - Nantes - France Hélène AUFFRET En recrutement Contact (sur clinicalTrials)
CHU de Poitiers - 86021 - Poitiers - France Pierre Jean SAULNIER En recrutement Contact (sur clinicalTrials)
CHU de Rennes - 35000 - Rennes - France Agathe GUENEGO En recrutement Contact (sur clinicalTrials)
CHU de Toulouse - 31059 - Toulouse - France Pierre GOURDY En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Major (adult subject over 18), with no upper age limit

- Enrolled in a social security scheme or beneficiary of such a scheme

- Agreement to participate (informed, written consent)

- Established diabetes (regardless the type of diabetes), known for at least 6 months
at inclusion

- Regular user of a glucose monitoring system for at least 3 months.

Non inclusion Criteria:

- Known hemoglobinopathy

- Inadequate use of the flash glucose monitoring system with a capture rate of less
than 70% of interstitial glucose measurements, during the 3 months preceding the
inclusion visit.

- Stage 5 renal insufficiency (CKD-EPI less than 15 mL/min/1.73 m2)

- Pregnant or breast-feeding

- Major under guardianship, curatorship or safeguard of justice

- Any situation assessed by the investigator as potentially prejudicial to the
participant's health as a result of participation in the study



- Treatment with corticosteroids in the 3 months preceding the visit

- Unusual acute situation (infection, very unusual physical activity, etc.) deemed
significant by the investigator

- Pregnancy started